<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE paragraph PUBLIC "-//IFRS//DTD DITA Paragraph//EN" "../../../DocTypes/com.ifrs.doctype/dtd/paragraph.dtd"><paragraph id="IFRS07_B52" base="F17296655"><paranum class="- topic/title paragraph/paranum "/><titlealts><navtitle>B52</navtitle></titlealts><prolog><data name="standard_number" value="IFRS 7"/><data name="paranum" value="B52"/></prolog><body><p id="IFRS07_P1177">Alternatively, an entity may group the quantitative disclosures required by <xref id="IFRS07_X1061" base="F17328121" href="IFRS07_13C.dita#IFRS07_13C">paragraph 13C(a)–(c)</xref> by type of financial instrument, and the quantitative disclosures required by <xref id="IFRS07_X1062" base="F17328120" href="IFRS07_13C.dita#IFRS07_13C">paragraph 13C(c)–(e)</xref> by counterparty. If an entity provides the required information by counterparty, the entity is not required to identify the counterparties by name. However, designation of counterparties (Counterparty A, Counterparty B, Counterparty C, etc) shall remain consistent from year to year for the years presented to maintain comparability. Qualitative disclosures shall be considered so that further information can be given about the types of counterparties. When disclosure of the amounts in <xref id="IFRS07_X1063" base="F17328119" href="IFRS07_13C.dita#IFRS07_13C">paragraph 13C(c)–(e)</xref> is provided by counterparty, amounts that are individually significant in terms of total counterparty amounts shall be separately disclosed and the remaining individually insignificant counterparty amounts shall be aggregated into one line item.</p></body></paragraph>